ArticleFrontiers in immunology2022

CD137 Agonists Targeting CD137-Mediated Negative Regulation Show Enhanced Antitumor Efficacy in Lung Cancer.

Ling Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.